Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Gene Silencing/Gene Editing » JP Morgan, Generex, AVI BioPharma, New York Academy of Sciences

JP Morgan, Generex, AVI BioPharma, New York Academy of Sciences

Jan 09, 2004
Premium

RNAi Companies to Present at JP Morgan Conference

The JP Morgan 22nd Annual Healthcare Conference is scheduled for Jan. 12-15 in San Francisco, and a number of RNAi companies are set to present.

Included on the conference’s roster are Alnylam Pharmaceuticals, Ambion, Promega, and Sirna Therapeutics.

Presentations will be webcast and can be found online at http://www.mapdigital.com/jpmorgan/healthcare04/welcome.html

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

A Few, as Expected

The US Centers for Disease Control and Prevention has identified a small group of breakthrough COVID-19 cases, the Wall Street Journal reports.

For the Unknown Soldiers

The New York Times reports that the US Department of Defense is to use genetic genealogy approaches to identify the remains of unknown soldiers.

Prep for the Next One

Vox and Nature discuss the importance of preparing for the next pandemic.

Nature Papers Compare CtDNA Assays, Examine Lettuce Domestication, More

In Nature this week: comparison of five circulating tumor DNA assays, resequencing analysis of lettuce gives insight into its domestication, and more.

Apr
21
Featured Webinar

Single-cell Multiomics Analysis of Clonal Evolution in Myeloid Malignancies

Sponsored by
Mission Bio

This webinar, the first in a “Meet the Authors” series sponsored by Mission Bio, will discuss the application of single-cell analysis to decipher clonal evolution across several stages of disease development in myeloid malignancies. 

Apr
23
Featured Webinar

Advances in Single-Cell Proteomics: Building a Complete Picture of Cellular Identity

Sponsored by
Isoplexis

Recent advances in single-cell technologies have provided unprecedented -omic-level insights into cellular heterogeneity and function. 

What's Popular?

In Gene Silencing/Gene Editing

  1. CRISPR-Cas9 Genome Editing Can Lead to Extensive Chromosome Rearrangements

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.